Skip to main content

Bristol Myers Squibb Alliance and other revenues

  • BMY · NYSE
  • Pharmaceuticals
  • S&P 500
$63.43+1.78%Close 13 Nov 2026 · Market value $128.9B

Alliance and other revenues at Bristol Myers Squibb came to $463.0M for the quarter to 30 Sep 2026, up 24.5% from a year earlier.

As Bristol Myers Squibb reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$309.0MDec 2023$306.0MMar 2024$276.0MJun 2024$409.0MSep 2024$531.0MDec 2024$315.0MMar 2025$360.0MJun 2025$372.0MSep 2025$391.0MDec 2025$321.0MMar 2026$385.0MJun 2026$463.0MSep 2026
Bristol Myers Squibb Alliance and other revenues, every reported period
Period endingAlliance and other revenuesChange on a yearFiled
30 Sep 2026$463.0Mup 24.5%29 Oct 2026
30 Jun 2026$385.0Mup 6.9%30 Jul 2026
31 Mar 2026$321.0Mup 1.9%30 Apr 2026
31 Dec 2025$391.0Mdown 26.4%11 Feb 2026
30 Sep 2025$372.0Mdown 9.0%30 Oct 2025
30 Jun 2025$360.0Mup 30.4%31 Jul 2025
31 Mar 2025$315.0Mup 2.9%24 Apr 2025
31 Dec 2024$531.0Mup 71.8%12 Feb 2025
30 Sep 2024$409.0Mup 27.4%31 Oct 2024
30 Jun 2024$276.0Mdown 10.7%26 Jul 2024
31 Mar 2024$306.0Mup 5.9%25 Apr 2024
31 Dec 2023$309.0Mdown 9.4%13 Feb 2024
30 Sep 2023$321.0Mdown 20.7%26 Oct 2023
30 Jun 2023$309.0Mdown 23.1%27 Jul 2023
31 Mar 2023$289.0Mdown 15.0%27 Apr 2023
31 Dec 2022$341.0M—14 Feb 2023
30 Sep 2022$405.0M—26 Oct 2022
30 Jun 2022$402.0M—27 Jul 2022
31 Mar 2022$340.0M—29 Apr 2022

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Bristol Myers Squibb: International revenues · Gross product sales · Net product sales · Growth Portfolio revenue · Legacy Portfolio revenue · Eliquis revenue · Opdivo revenue · Orencia revenue · Yervoy revenue · Reblozyl revenue · Breyanzi revenue · Camzyos revenue · Opdualag revenue · Opdivo Qvantig revenue · Revlimid revenue · Zeposia revenue · Pomalyst/Imnovid revenue · Abecma revenue · Sotyktu revenue · Alliance revenues · Sprycel revenue · Abraxane revenue · Krazati revenue · Cobenfy revenue · financial statements

Every KPI and segment of BMY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.